文献速递糖尿病

胰岛T细胞浸润的范围与幅度可作为定义1型糖尿病进展的有力工具

The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes.
PubMed 文献 · Diabetologia · 2023-03-08

研究利用15例非糖尿病、8例双自身抗体阳性和10例1型糖尿病(病程0-2年)供者的胰腺组织,定量8661个胰岛的T细胞浸润。结果显示浸润胰岛比例和T细胞密度随疾病进展显著变化,并提出「30-30规则」以高特异性和敏感性区分非糖尿病与1型糖尿病供者。

要点

  • 双自身抗体阳性者已有33%胰岛被1-5个CD3+细胞浸润,提示浸润早于临床诊断。
  • 1型糖尿病供者胰岛T细胞密度为74.8 CD3+细胞/mm2,高于非糖尿病者的17.3 CD3+细胞/mm2。
  • 「30-30规则」可高特异性和敏感性区分非糖尿病与1型糖尿病供者。

核心结论

  • 数据表明浸润胰岛比例和T细胞密度在1型糖尿病进程中剧烈变化,这些变化在双自身抗体阳性个体中已可观察到。
  • 提示随疾病进展T细胞浸润扩展至全胰腺,累及胰岛和外分泌区,主要靶向含胰岛素胰岛,但大量细胞聚集罕见。

研究设计与样本

  • 从Network for Pancreatic Organ Donors with Diabetes获取15例非糖尿病、8例双自身抗体阳性和10例1型糖尿病(病程0-2年)器官供者的胰腺组织切片。
  • 用免疫荧光染色胰岛素、胰高血糖素、CD3和CD8,使用QuPath软件定量总共8661个胰岛的T细胞浸润。

主要发现

  • 非糖尿病供者17.1%胰岛、自身抗体阳性供者33%胰岛和1型糖尿病供者32.5%胰岛被1至5个CD3+细胞浸润。
  • 被≥6个CD3+细胞浸润的胰岛在非糖尿病供者中罕见(0.4%),自身抗体阳性供者4.5%,1型糖尿病供者8.2%。
  • 自身抗体阳性供者胰岛T细胞密度55.4 CD3+细胞/mm2和1型糖尿病供者74.8 CD3+细胞/mm2均显著高于非糖尿病个体17.3 CD3+细胞/mm2,1型糖尿病个体外分泌区T细胞密度也更高。
  • 分析至少30个胰岛并使用T细胞密度参考均值30 CD3+细胞/mm2(30-30规则)能以高特异性和敏感性区分非糖尿病与1型糖尿病供者,并将自身抗体阳性个体分类为非糖尿病样或1型糖尿病样。

关键数值与推荐

  • 浸润胰岛比例:非糖尿病供者17.1%,自身抗体阳性供者33%,1型糖尿病供者32.5%(1-5个CD3+细胞)。
  • ≥6个CD3+细胞浸润胰岛比例:非糖尿病供者0.4%,自身抗体阳性供者4.5%,1型糖尿病供者8.2%。
  • 胰岛T细胞密度:非糖尿病供者17.3 CD3+细胞/mm2,自身抗体阳性供者55.4 CD3+细胞/mm2,1型糖尿病供者74.8 CD3+细胞/mm2。
  • 30-30规则:至少分析30个胰岛,T细胞密度参考均值30 CD3+细胞/mm2。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Insulitis is not present in all islets, and it is elusive in humans. Although earlier studies focused on islets that fulfilled certain criteria (e.g. ≥15 CD45+ cells or ≥6 CD3+ cells), there is a fundamental lack of understanding of the infiltration dynamics in terms of its magnitude (i.e. how much) and extent (i.e. where). Here, we aimed to perform an in-depth characterisation of T cell infiltration by investigating islets with moderate (1-5 CD3+ cells) and high (≥6 CD3+ cells) infiltration in individuals with and without type 1 diabetes. METHODS: Pancreatic tissue sections from 15 non-diabetic, eight double autoantibody-positive and ten type 1 diabetic (0-2 years of disease duration) organ donors were obtained from the Network for Pancreatic Organ Donors with Diabetes, and stained for insulin, glucagon, CD3 and CD8 by immunofluorescence. T cell infiltration was quantified in a total of 8661 islets using the software QuPath. The percentage of infiltrated islets and islet T cell density were calculated. To help standardise the analysis of T cell infiltration, we used cell density data to develop a new T cell density threshold capable of differentiating non-diabetic and type 1 diabetic donors. RESULTS: Our analysis revealed that 17.1% of islets in non-diabetic donors, 33% of islets in autoantibody-positive and 32.5% of islets in type 1 diabetic donors were infiltrated by 1 to 5 CD3+ cells. Islets infiltrated by ≥6 CD3+ cells were rare in non-diabetic donors (0.4%) but could be found in autoantibody-positive (4.5%) and type 1 diabetic donors (8.2%). CD8+ and CD8- populations followed similar patterns. Likewise, T cell density was significantly higher in the islets of autoantibody-positive donors (55.4 CD3+ cells/mm2) and type 1 diabetic donors (74.8 CD3+ cells/mm2) compared with non-diabetic individuals (17.3 CD3+ cells/mm2), which was accompanied by higher exocrine T cell density in type 1 diabetic individuals. Furthermore, we showed that the analysis of a minimum of 30 islets and the use of a reference mean value for T cell density of 30 CD3+ cells/mm2 (the 30-30 rule) can differentiate between non-diabetic and type 1 diabetic donors with high specificity and sensitivity. In addition, it can classify autoantibody-positive individuals as non-diabetic or type 1 diabetic-like. CONCLUSIONS/INTERPRETATION: Our data indicates that the proportion of infiltrated islets and T cell density change dramatically during the course of type 1 diabetes, and these changes can be already observed in double autoantibody-positive individuals. This suggests that, as disease progresses, T cell infiltration extends throughout the pancreas, reaching the islets and exocrine compartment. While it predominantly targets insulin-containing islets, large accumulations of cells are rare. Our study fulfils the need to further understand T cell infiltration, not only after diagnosis but also in individuals with diabetes-related autoantibodies. Furthermore, the development and application of new analytical tools based on T cell infiltration, like the 30-30 rule, will allow us to correlate islet infiltration with demographic and clinical variables with the aim of identifying individuals at the very early stages of the disease.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J, et al. The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes. Diabetologia. 2023. PMID: 36884056. doi:10.1007/s00125-023-05888-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。